Search Results - "Patten, S.B."

Refine Results
  1. 1

    Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis by Fiest, K.M, Walker, J.R, Bernstein, C.N, Graff, L.A, Zarychanski, R, Abou-Setta, A.M, Patten, S.B, Sareen, J, Bolton, J.M, Marriott, J.J, Fisk, J.D, Singer, A, Marrie, R.A

    Published in Multiple sclerosis and related disorders (01-01-2016)
    “…Abstract Background Depression and anxiety are common in persons with multiple sclerosis (MS), and adversely affect fatigue, medication adherence, and quality…”
    Get full text
    Journal Article
  2. 2

    Determinants and incidence of depression in multiple sclerosis: A prospective cohort study by Berzins, S.A, Bulloch, A.G, Burton, J.M, Dobson, K.S, Fick, G.H, Patten, S.B

    Published in Journal of psychosomatic research (01-08-2017)
    “…Abstract Objective To estimate the incidence and explore potential determinants of incidence of depression in MS. Methods A prospective cohort study used a…”
    Get full text
    Journal Article
  3. 3

    Understanding the impact of COVID-19 isolation measures on individuals with mood disorders in mental health clinics by Rodrigues, C., Patten, S.B., Smith, E.E., Roach, P.

    Published in Journal of affective disorders reports (01-04-2022)
    “…•Participants adapted well to virtual psychiatric care.•Concerns over virtual care stemmed from meeting a new care practitioner through virtual…”
    Get full text
    Journal Article
  4. 4

    Patterns of disability, care needs, and quality of life of people with Parkinson’s disease in a general population sample by Terriff, D.L, Williams, J.V.A, Patten, S.B, Lavorato, D.H, Bulloch, A.G.M

    Published in Parkinsonism & related disorders (01-08-2012)
    “…Abstract Objective To quantify patterns of disability, care needs, and quality of life in a national community-dwelling sample of people with Parkinson’s…”
    Get full text
    Journal Article
  5. 5

    Comorbidity is associated with pain-related activity limitations in multiple sclerosis by Fiest, K.M, Fisk, J.D, Patten, S.B, Tremlett, H, Wolfson, C, Warren, S, McKay, K.A, Berrigan, L, Marrie, R.A

    Published in Multiple sclerosis and related disorders (01-09-2015)
    “…Abstract Background Comorbidities are common in multiple sclerosis (MS). The high prevalence of pain in MS is well-established but the influence of…”
    Get full text
    Journal Article
  6. 6

    EPA-0944 - Development and validation of a prediction algorithm for recurrence of major depression by Wang, J.L, Patten, S.B, Sareen, J, Bolton, J, Schmitz, N, MacQueen, G

    Published in European psychiatry (2014)
    “…Objectives To develop and validate a prognostic model for predicting recurrence of major depression using data from a population-based, nationally…”
    Get full text
    Journal Article
  7. 7

    Diabetes, cardiovascular disease, and health care use in people with and without schizophrenia by Bresee, L.C, Majumdar, S.R, Patten, S.B, Johnson, J.A

    Published in European psychiatry (01-07-2011)
    “…Abstract Purpose To compare the prevalence of cardiovascular risk factors (CV-RF) and disease (CV-D) and health care use in people with and without…”
    Get full text
    Journal Article
  8. 8

    The Cost of Intracerebral Haemorrhage: A Canadian Example by Specogna, A.V, Hill, M.D, Patten, S.B

    Published in Annals of epidemiology (2007)
    “…Purpose Primary Intracerebral Haemorrhage (ICH) is one of the most devastating forms of stroke with substantial morbidity and mortality. Although the human…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Efficacy and adverse events of oral isotretinoin for acne: a systematic review by Vallerand, I.A., Lewinson, R.T., Farris, M.S., Sibley, C.D., Ramien, M.L., Bulloch, A.G.M., Patten, S.B.

    Published in British journal of dermatology (1951) (01-01-2018)
    “…Summary Despite many years of clinical use of isotretinoin, a comprehensive review of evidence for isotretinoin therapy in patients with acne is lacking. We…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Efficacy and adverse events of oral isotretinoin for acne: a systematic review by Vallerand, I.A., Lewinson, R.T., Farris, M.S., Sibley, C.D., Ramien, M.L., Bulloch, A.G.M., Patten, S.B.

    Published in British journal of dermatology (1951) (01-01-2018)
    “…Summary Acne vulgaris, usually just referred to as acne, is the most common skin disease. It causes red spots, pus‐filled spots and blackheads and can vary in…”
    Get full text
    Journal Article
  18. 18

    Is depression screening in patients with acne critical?: reply from authors by Vallerand, I.A., Lewinson, R.T., Parsons, L.M., Lowerison, M.W., Frolkis, A.D., Kaplan, G.G., Barnabe, C., Bulloch, A.G.M., Patten, S.B.

    Published in British journal of dermatology (1951) (01-07-2018)
    “…Linked Articles: Unrue and Feldman. Br J Dermatol 2018; 179:226–227. Vallerand et al. Br J Dermatol 2018; 178:e194–5…”
    Get full text
    Journal Article
  19. 19

    The role of systematic reviews and meta-analyses of incidence and prevalence studies in neuroepidemiology by Fiest, K M, Pringsheim, T, Patten, S B, Svenson, L W, Jetté, N

    Published in Neuroepidemiology (01-01-2014)
    “…Systematic reviews and meta-analyses on the incidence and prevalence of neurological conditions are important methods of quantifying the burden and risk of…”
    Get more information
    Journal Article
  20. 20

    Antidepressant dose and the risk of deliberate self-harm by Barbui, C., Patten, S.B.

    Published in Epidemiology and psychiatric sciences (01-12-2014)
    “…Although the mechanism by which antidepressants (ADs) may increase the risk of suicide-related outcomes is unknown, it has been hypothesised that some adverse…”
    Get full text
    Journal Article